People: Pressure Biosciences Inc (PBIO.PK)
0.36USD
17 May 2013
$-0.02 (-5.26%)
$0.38
$0.36
$0.36
$0.36
5,700
35,703
$0.63
$0.15
Lawrence, Nathan
Brief Biography
Dr. Nathan P. Lawrence, Ph.D., is Vice President - Marketing of Pressure BioSciences, Inc. He was appointed as Vice President of Marketing and Sales on April 1, 2006. Dr. Lawrence joined Pressure BioSciences Inc. in 2005, serving as Director of Research and Development until his promotion to Vice President of Marketing in 2006. Dr. Lawrence was responsible for the development of protocols based on Pressure Cycling Technology (PCT). From 2004 through 2005, Dr. Lawrence worked for 454 Life Sciences Inc., in product development. Prior to 454 Life Sciences, Dr. Lawrence was Director of Research and Development for Boston Biomedica, Inc. from 1998 to 2004. He was primarily responsible for the development of PCT, as well as the development of nucleic acid-based diagnostic assays. Prior to joining Boston Biomedica, Inc., Dr. Lawrence held several positions with increasing responsibility in Research and Development and manufacturing at Becton Dickinson and Gene Trak Systems. Dr. Lawrence holds a BA from the University of Miami, an M.S. from Southern Connecticut State University, and a Ph.D. from Yale University.
Basic Compensation
| Total Annual Compensation, USD | Long-Term Incentive Plans, USD | All Other, USD | Fiscal Year Total, USD |
|---|---|---|---|
| 146,495 | -- | 1,627 | 180,825 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Jeffery Peterson |
-- |
Richard Schumacher |
328,640 |
Conrad Mir |
-- |
Edmund Ting |
210,773 |
Nathan Lawrence |
180,825 |
Alexander Lazarev |
190,936 |

